Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
How to facilitate the wider use of pharmacogenetic tests?
Verstuyft C, Dewolf D, Blin O, Florentin V, Mesnard L, Chaumette B, Ayme-Dietrich E, Raymond L, Lang M, Lamazière A, Allard B, Samelson L, Lamezec L, Loriot MA, Le Bozec A, Picard N. Verstuyft C, et al. Among authors: lang m. Therapie. 2024 Dec 20:S0040-5957(24)00215-4. doi: 10.1016/j.therap.2024.11.010. Online ahead of print. Therapie. 2024. PMID: 39788802
Single-Cell Heterogeneity of EGFR Pathway Is Linked to Unique Signatures of Drug Response and Malignancy in Patient Derived Glioblastoma Stem Cells.
Masterman-Smith MD, Graham NA, Panosyan EH, Mottahedeh J, Samuels ER, Nunez A, Phillips T, Choe M, Cloughesy TF, Lazareff JA, Liau LM, Yong WH, Graeber TG, Kornblum HI, Lang MF, Li Y, Sun J. Masterman-Smith MD, et al. Among authors: lang mf. Cancer Res Treat. 2025 Jan 7. doi: 10.4143/crt.2024.859. Online ahead of print. Cancer Res Treat. 2025. PMID: 39788641
[Expert consensus on ethical requirements for artificial intelligence (AI) processing medical data].
Li C, Zhang XY, Wu YH, Yang XL, Yu HR, Jin HB, Li YB, Zhu ZH, Liu R, Liu N, Xie Y, Lyu LL, Zhu XH, Tang H, Li HF, Li HL, Zeng XJ, Chen ZX, Fan XF, Wang Y, Wu ZJ, Wu ZQ, Guan YQ, Xue MM, Luo B, Wang AM, Yang XW, Ying Y, Yang XH, Huang XZ, Lang MF, Chen SM, Zhang HH, Zhang Z, Huang W, Xu GB, Liu JQ, Song T, Xiao J, Xia YL, Guan YF, Zhu L. Li C, et al. Among authors: lang mf. Sheng Li Xue Bao. 2024 Dec 25;76(6):937-942. Sheng Li Xue Bao. 2024. PMID: 39780570 Review. Chinese.
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.
Lopez J, Powles T, Braiteh F, Siu LL, LoRusso P, Friedman CF, Balmanoukian AS, Gordon M, Yachnin J, Rottey S, Karydis I, Fisher GA, Schmidt M, Schuler M, Sullivan RJ, Burris HA, Galvao V, Henick BS, Dirix L, Jaeger D, Ott PA, Wong KM, Jerusalem G, Schiza A, Fong L, Steeghs N, Leidner RS, Rittmeyer A, Laurie SA, Gort E, Aljumaily R, Melero I, Sabado RL, Rhee I, Mancuso MR, Muller L, Fine GD, Yadav M, Kim L, Leveque VJP, Robert A, Darwish M, Qi T, Zhu J, Zhang J, Twomey P, Rao GK, Low DW, Petry C, Lo AA, Schartner JM, Delamarre L, Mellman I, Löwer M, Müller F, Derhovanessian E, Cortini A, Manning L, Maurus D, Brachtendorf S, Lörks V, Omokoko T, Godehardt E, Becker D, Hawner C, Wallrapp C, Albrecht C, Kröner C, Tadmor AD, Diekmann J, Vormehr M, Jork A, Paruzynski A, Lang M, Blake J, Hennig O, Kuhn AN, Sahin U, Türeci Ö, Camidge DR. Lopez J, et al. Among authors: lang m. Nat Med. 2025 Jan 6. doi: 10.1038/s41591-024-03334-7. Online ahead of print. Nat Med. 2025. PMID: 39762422
2,135 results